Urine and plasma free phenytoin concentration correlation. 1982

D T Casto, and T M Ludden, and J M Bertoni, and L C Littlefield, and R A Sagraves, and R W Mackey

In an attempt to find a simple, noninvasive method for estimating the plasma free concentration (CPf) of phenytoin (PHT), the relationship between urine PHT concentration (Cu) and CPf was studied in 40 epileptic patients who were 6 to 50 yr old. Cu was determined by gas-liquid chromatography and CPf by equilibrium dialysis at 37 degrees. Cu was generally greater than CPf, but correlation between the two was strong (r2 = 0.876) and in the same range as previously published results for saliva and CPf. Correlation of Cu with CPf was not influenced by patient age, urine pH, or urine flow rate. In 24 patients timed urine collections were obtained and calculated renal clearances of PHT were shown to increase in proportion to urine flow rates. Although it is not known if renal impairment and albuminuria will alter the relationship between Cu and CPf it appears that Cu may be useful in estimating the concentration of pharmacologically active PHT in plasma.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D T Casto, and T M Ludden, and J M Bertoni, and L C Littlefield, and R A Sagraves, and R W Mackey
January 1984, British journal of clinical pharmacology,
D T Casto, and T M Ludden, and J M Bertoni, and L C Littlefield, and R A Sagraves, and R W Mackey
September 1976, Neurology,
D T Casto, and T M Ludden, and J M Bertoni, and L C Littlefield, and R A Sagraves, and R W Mackey
February 1978, Epilepsia,
D T Casto, and T M Ludden, and J M Bertoni, and L C Littlefield, and R A Sagraves, and R W Mackey
January 1979, Clinical toxicology,
D T Casto, and T M Ludden, and J M Bertoni, and L C Littlefield, and R A Sagraves, and R W Mackey
January 1986, Therapeutic drug monitoring,
D T Casto, and T M Ludden, and J M Bertoni, and L C Littlefield, and R A Sagraves, and R W Mackey
January 2018, Clinical pharmacology : advances and applications,
D T Casto, and T M Ludden, and J M Bertoni, and L C Littlefield, and R A Sagraves, and R W Mackey
July 1988, Pharmacological research communications,
D T Casto, and T M Ludden, and J M Bertoni, and L C Littlefield, and R A Sagraves, and R W Mackey
December 1984, British journal of clinical pharmacology,
D T Casto, and T M Ludden, and J M Bertoni, and L C Littlefield, and R A Sagraves, and R W Mackey
November 1990, The Journal of pharmacy and pharmacology,
D T Casto, and T M Ludden, and J M Bertoni, and L C Littlefield, and R A Sagraves, and R W Mackey
June 1995, The Annals of pharmacotherapy,
Copied contents to your clipboard!